Image For Activity Cover
Late-Breaking Clinical Trials - Randomized Trials
Description

This session presents the latest in comparative science showcasing the evidence-based process that informs our practice.

Scheduled Interactive Session
Meet the Trialists: 11:00 AM EDT, Friday, May 8, 2020
To attend the scheduled sessions, please log in to Heart Rhythm 365.

Presentations

Moderator:              Andrew D. Krahn, MD, FHRS, Division of Cardiology 
                                 University of British Columbia, Vancouver, BC, Canada

Commentators:      Sana M. Al-Khatib, MD, MHS, FHRS, CCDS
                                 Duke University Medical Center, Durham, NC

                                 Eric N. Prystowsky, MD, FHRS
                                 St. Vincent Hospital and Health Center, Indianapolis, IN

LBCT & Submitting Authors

Etripamil Nasal Spray For Acute Termination Of Spontaneous Episodes Of Paroxysmal Supraventricular Tachycardia (Node-301)

Bruce S. Stambler. MD, FHRS, Piedmont Heart Institute, Atlanta, GA

A Randomized Trial Of Subcutaneous Versus Transvenous Defibrillator Therapy: The PRAETORIAN Trial

Reinoud Knops, MD, PhD, Academic Medical Center, Hilversum, Netherlands 

Convergence Of Epicardial And Endocardial Rf Ablation For The Treatment Of Symptomatic Persistent AF

David De Lugio, MD, FHRS, Emory Saint Joseph`s Hospital, Atlanta, GA 

Persistent Atrial Fibrillation Ablation With A Contact Force Sensing Catheter: The Prospective Multicenter Precept Trial

Moussa Mansour, MD, FHRS, Massachusetts General Hospital, Boston, MA

Smart Watches Significantly Improve Adherence To Oral Anticoagulation Therapy Among Patients With Atrial Fibrillation

Zhan Shi, MD, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China

Disclosures

Moderator 
A. D. Krahn:
  Honoraria/Speaking/Consulting Fee - Medtronic.

Commentators
S. M. Al-Khatib:
  Honoraria/Speaking/Consulting Fee - Milestone Pharmaceuticals; Medtronic.

E. N. Prystowsky:  Honoraria/Speaking/Consulting Fee - CardioNet, Inc.; Medtronic. Stock or Stock Options - Public - Stereotaxis, Inc..

Presenters:

B.S. Stambler: Honoraria/Speaking/Consulting Fee: Boston Scientific, Milestone. Research (Contracted Grants for PIs and Named Investigators only): Biotronik, Milestone

R. Knops: Honoraria/Speaking/Consulting Fee, Cairdac, Medtonic, Boston Scientific, Abbott. Stock or Stock Options: AtaCor Medical Inc. 

D. De Lugio: Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, AtriCure Inc

M. Mansour: Research (Contracted Grants for PIs and Name Only: Abbott, Biosense Webster. Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster. Stock or Stock Options: NewPace Ltd

Z. Shi: Nothing to Disclose

Summary
Availability: On-Demand
Cost: FREE
Credit Offered: No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Powered By